Faculte de Medecine de Lille
Seven variant CYP4F12 allozymes characterized
Published in Genetics and Environmental Business Week, February 24th, 2005
"The human cytochrome CYP4F12 has been shown to be metabolically active toward inflammatory mediators and exogenous compounds such as antihistaminic drugs," according to scientists in France, who "recently identified a genetic polymorphism within the promoter region, associated with a decreased level of enzyme expression."
In their subsequent study, C. Cauffiez and coauthors at the Faculte de Medecine de Lille sought to achieve "the further identification of single nucleotide polymorphisms in the coding sequence of the CYP4F12 gene."
"A polymerase chain...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Genetics and Environmental Business Week
More Articles from Genetics and Environmental Business Week
- Celera Genomics Group
Genomics firm reports loss of $0.27 per share - Icoria, Inc.
Biotech company signs CRADA with U.S. Army Edgewood Chemical Biological Center - Microtek Medical Holdings, Inc.
Infection control product provider anticipates financial results - Perlegen Sciences, Inc.
Pharma company signs new agreement with AstraZeneca - Scinoa, Ltd.
Biotech company relocates to Colorado from U.K., hires James Bruce as CEO - St. Francis Medical Technologies, Inc.
Company focused on devices for lumbar spinal stenosis names Michael Bates CFO - More from this issue of Genetics and Environmental Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
